274 related articles for article (PubMed ID: 33453462)
1. Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19.
Valenti L; Griffini S; Lamorte G; Grovetti E; Uceda Renteria SC; Malvestiti F; Scudeller L; Bandera A; Peyvandi F; Prati D; Meroni P; Cugno M
J Autoimmun; 2021 Feb; 117():102595. PubMed ID: 33453462
[TBL] [Abstract][Full Text] [Related]
2. Genomewide Association Study of Severe Covid-19 with Respiratory Failure.
; Ellinghaus D; Degenhardt F; Bujanda L; Buti M; Albillos A; Invernizzi P; Fernández J; Prati D; Baselli G; Asselta R; Grimsrud MM; Milani C; Aziz F; Kässens J; May S; Wendorff M; Wienbrandt L; Uellendahl-Werth F; Zheng T; Yi X; de Pablo R; Chercoles AG; Palom A; Garcia-Fernandez AE; Rodriguez-Frias F; Zanella A; Bandera A; Protti A; Aghemo A; Lleo A; Biondi A; Caballero-Garralda A; Gori A; Tanck A; Carreras Nolla A; Latiano A; Fracanzani AL; Peschuck A; Julià A; Pesenti A; Voza A; Jiménez D; Mateos B; Nafria Jimenez B; Quereda C; Paccapelo C; Gassner C; Angelini C; Cea C; Solier A; Pestaña D; Muñiz-Diaz E; Sandoval E; Paraboschi EM; Navas E; García Sánchez F; Ceriotti F; Martinelli-Boneschi F; Peyvandi F; Blasi F; Téllez L; Blanco-Grau A; Hemmrich-Stanisak G; Grasselli G; Costantino G; Cardamone G; Foti G; Aneli S; Kurihara H; ElAbd H; My I; Galván-Femenia I; Martín J; Erdmann J; Ferrusquía-Acosta J; Garcia-Etxebarria K; Izquierdo-Sanchez L; Bettini LR; Sumoy L; Terranova L; Moreira L; Santoro L; Scudeller L; Mesonero F; Roade L; Rühlemann MC; Schaefer M; Carrabba M; Riveiro-Barciela M; Figuera Basso ME; Valsecchi MG; Hernandez-Tejero M; Acosta-Herrera M; D'Angiò M; Baldini M; Cazzaniga M; Schulzky M; Cecconi M; Wittig M; Ciccarelli M; Rodríguez-Gandía M; Bocciolone M; Miozzo M; Montano N; Braun N; Sacchi N; Martínez N; Özer O; Palmieri O; Faverio P; Preatoni P; Bonfanti P; Omodei P; Tentorio P; Castro P; Rodrigues PM; Blandino Ortiz A; de Cid R; Ferrer R; Gualtierotti R; Nieto R; Goerg S; Badalamenti S; Marsal S; Matullo G; Pelusi S; Juzenas S; Aliberti S; Monzani V; Moreno V; Wesse T; Lenz TL; Pumarola T; Rimoldi V; Bosari S; Albrecht W; Peter W; Romero-Gómez M; D'Amato M; Duga S; Banales JM; Hov JR; Folseraas T; Valenti L; Franke A; Karlsen TH
N Engl J Med; 2020 Oct; 383(16):1522-1534. PubMed ID: 32558485
[TBL] [Abstract][Full Text] [Related]
3. Complement activation predicts negative outcomes in COVID-19: The experience from Northen Italian patients.
Meroni PL; Croci S; Lonati PA; Pregnolato F; Spaggiari L; Besutti G; Bonacini M; Ferrigno I; Rossi A; Hetland G; Hollan I; Cugno M; Tedesco F; Borghi MO; Salvarani C
Autoimmun Rev; 2023 Jan; 22(1):103232. PubMed ID: 36414219
[TBL] [Abstract][Full Text] [Related]
4. Complement activation and endothelial perturbation parallel COVID-19 severity and activity.
Cugno M; Meroni PL; Gualtierotti R; Griffini S; Grovetti E; Torri A; Lonati P; Grossi C; Borghi MO; Novembrino C; Boscolo M; Uceda Renteria SC; Valenti L; Lamorte G; Manunta M; Prati D; Pesenti A; Blasi F; Costantino G; Gori A; Bandera A; Tedesco F; Peyvandi F
J Autoimmun; 2021 Jan; 116():102560. PubMed ID: 33139116
[TBL] [Abstract][Full Text] [Related]
5. Measuring Circulating Complement Activation Products in Myeloperoxidase- and Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Wu EY; McInnis EA; Boyer-Suavet S; Mendoza CE; Aybar LT; Kennedy KB; Poulton CJ; Henderson CD; Hu Y; Hogan SL; Hu P; Xiao H; Nachman PH; Jennette JC; Falk RJ; Bunch DO
Arthritis Rheumatol; 2019 Nov; 71(11):1894-1903. PubMed ID: 31215772
[TBL] [Abstract][Full Text] [Related]
6. A disturbed balance between blood complement protective factors (FH, ApoE) and common pathway effectors (C5a, TCC) in acute COVID-19 and during convalesce.
Laudanski K; Okeke T; Siddiq K; Hajj J; Restrepo M; Gullipalli D; Song WC
Sci Rep; 2022 Aug; 12(1):13658. PubMed ID: 35953544
[TBL] [Abstract][Full Text] [Related]
7. C5a elevation in convalescents from severe COVID-19 is not associated with early complement activation markers C3bBbP or C4d.
Kowalska D; Kuźniewska A; Senent Y; Tavira B; Inogés S; López-Díaz de Cerio A; Pio R; Okrój M; Yuste JR
Front Immunol; 2022; 13():946522. PubMed ID: 36091057
[TBL] [Abstract][Full Text] [Related]
8. Persistence of High Levels of Serum Complement C5a in Severe COVID-19 Cases After Hospital Discharge.
Senent Y; Inogés S; López-Díaz de Cerio A; Blanco A; Campo A; Carmona-Torre F; Sunsundegui P; González-Martín A; Ajona D; Okrój M; Prósper F; Pio R; Yuste JR; Tavira B
Front Immunol; 2021; 12():767376. PubMed ID: 34868021
[TBL] [Abstract][Full Text] [Related]
9. Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.
Shelton JF; Shastri AJ; Ye C; Weldon CH; Filshtein-Sonmez T; Coker D; Symons A; Esparza-Gordillo J; ; Aslibekyan S; Auton A
Nat Genet; 2021 Jun; 53(6):801-808. PubMed ID: 33888907
[TBL] [Abstract][Full Text] [Related]
10. The major genetic risk factor for severe COVID-19 is inherited from Neanderthals.
Zeberg H; Pääbo S
Nature; 2020 Nov; 587(7835):610-612. PubMed ID: 32998156
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the genetic risk for COVID-19 outcomes in COPD and differences among worldwide populations.
Marçalo R; Neto S; Pinheiro M; Rodrigues AJ; Sousa N; Santos MAS; Simão P; Valente C; Andrade L; Marques A; Moura GR
PLoS One; 2022; 17(2):e0264009. PubMed ID: 35196333
[TBL] [Abstract][Full Text] [Related]
12. ABO blood groups, COVID-19 infection and mortality.
Lehrer S; Rheinstein PH
Blood Cells Mol Dis; 2021 Jul; 89():102571. PubMed ID: 33894687
[TBL] [Abstract][Full Text] [Related]
13. Escalated complement activation during hospitalization is associated with higher risk of 60-day mortality in SARS-CoV-2-infected patients.
Barratt-Due A; Pettersen K; Børresdatter-Dahl T; Holter JC; Grønli RH; Dyrhol-Riise AM; Lerum TV; Holten AR; Tonby K; Trøseid M; Skjønsberg OH; Granerud BK; Heggelund L; Kildal AB; Schjalm C; Aaløkken TM; Aukrust P; Ueland T; Mollnes TE; Halvorsen B;
J Intern Med; 2024 Jul; 296(1):80-92. PubMed ID: 38539241
[TBL] [Abstract][Full Text] [Related]
14. CRISPRi links COVID-19 GWAS loci to LZTFL1 and RAVER1.
Fink-Baldauf IM; Stuart WD; Brewington JJ; Guo M; Maeda Y
EBioMedicine; 2022 Jan; 75():103806. PubMed ID: 34998241
[TBL] [Abstract][Full Text] [Related]
15. Initial study on TMPRSS2 p.Val160Met genetic variant in COVID-19 patients.
Wulandari L; Hamidah B; Pakpahan C; Damayanti NS; Kurniati ND; Adiatmaja CO; Wigianita MR; Soedarsono ; Husada D; Tinduh D; Prakoeswa CRS; Endaryanto A; Puspaningsih NNT; Mori Y; Lusida MI; Shimizu K; Oceandy D
Hum Genomics; 2021 May; 15(1):29. PubMed ID: 34001248
[TBL] [Abstract][Full Text] [Related]
16. Association between ABO blood types and coronavirus disease 2019 (COVID-19), genetic associations, and underlying molecular mechanisms: a literature review of 23 studies.
Zhang Y; Garner R; Salehi S; La Rocca M; Duncan D
Ann Hematol; 2021 May; 100(5):1123-1132. PubMed ID: 33686492
[TBL] [Abstract][Full Text] [Related]
17. Relative inefficiency of terminal complement activation.
Bhakdi S; Fassbender W; Hugo F; Carreno MP; Berstecher C; Malasit P; Kazatchkine MD
J Immunol; 1988 Nov; 141(9):3117-22. PubMed ID: 3262681
[TBL] [Abstract][Full Text] [Related]
18. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes.
Reynolds R; Hartnett ME; Atkinson JP; Giclas PC; Rosner B; Seddon JM
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5818-27. PubMed ID: 19661236
[TBL] [Abstract][Full Text] [Related]
19. A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity.
Michelis R; Tadmor T; Barhoum M; Shehadeh M; Shvidel L; Aviv A; Stemer G; Dally N; Rahimi-Levene N; Yuklea M; Braester A
PLoS One; 2019; 14(1):e0209024. PubMed ID: 30601845
[TBL] [Abstract][Full Text] [Related]
20. Genetic association of IL17 and the importance of ABO blood group antigens in saliva to COVID-19.
Nishida N; Sugiyama M; Kawai Y; Naka I; Iwamoto N; Suzuki T; Suzuki M; Miyazato Y; Suzuki S; Izumi S; Hojo M; Tsuchiura T; Ishikawa M; Ohashi J; Ohmagari N; Tokunaga K; Mizokami M
Sci Rep; 2022 Mar; 12(1):3854. PubMed ID: 35264675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
